Literature DB >> 6064868

Purification of antihemophilic factor (AHF) for clinical and experimental use.

A J Johnson, J Newman, M B Howell, S Puszkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6064868

Source DB:  PubMed          Journal:  Thromb Diath Haemorrh Suppl        ISSN： 0375-9997


× No keyword cloud information.
  4 in total

Review 1.  Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome.

Authors:  Yoshihiro Fujimura; Masanori Matsumoto; Hideo Yagi; Akira Yoshioka; Taei Matsui; Koiti Titani
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

2.  The subunit structure of normal and hemophilic factor VIII.

Authors:  G A Shapiro; J C Andersen; S V Pizzo; P A McKee
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

3.  Von Willebrand factor and platelet adhesiveness.

Authors:  D Meyer; M J Larrieu
Journal:  J Clin Pathol       Date:  1970-04       Impact factor: 3.411

4.  Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.

Authors:  T S Zimmerman; O D Ratnoff; A E Powell
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.